Separation Agreement and General Release between ContraVir Pharmaceuticals, Inc. and James Sapirstein dated as of October 18, 2018
Exhibit 10.2
SETTLEMENT AGREEMENT AND GENERAL RELEASE
1. This Separation Agreement and General Release (Agreement) is between James Sapirstein (Employee) and ContraVir Pharmaceuticals, Inc. (the Company) to resolve any and all outstanding issues between the parties and to set forth all of the obligations between the parties.
2. The Company terminated Employees employment effective as of October 15, 2018 (the Release Date) without Cause as such term is defined in the Amended and Restated Executive Agreement, effective as of May 25, 2017, by and between Employee and the Company (the Employment Agreement). The Company provided Employee with notice of such termination without Cause on October 1, 2018 (the Notice Date) and Employee resigned as a member of the Companys Board of Directors on October 2, 2018. Employee acknowledges and agrees that, except as provided in the following sentence, the Company has paid him all accrued compensation or benefits that accrued through the Release Date including, but not limited to, Employees Base Salary (as such term is defined in the Employment Agreement) through and including the Release Date. The Company and Employee acknowledge that Employee is owed an additional $36,923.00, which represents Employees twenty (20) accrued, but unused, vacation days as of the Release Date, and the Company agrees to make such $36,923.00 payment to Employee by not later than October 31, 2018.
3. In exchange for Employees execution and non-revocation of this Agreement on or within sixty (60) days after the Release Date and in exchange for the other obligations that Employee owes to the Company under this Agreement, the Company agrees to:
(i) deliver a check made payable to James Sapirstein in the amount of Fifty Nine Thousand One Hundred Seventy Eight Dollars and Eight Cents ($59,178.08), which constitutes forty-five (45) days of Employees Base Salary and is being paid to Employee in lieu of the remaining notice obligations, if any, set forth in the Employment Agreement; and
(ii) deliver a check made payable to James Sapirstein in the amount of Seven Hundred and Twenty Thousand Dollars ($720,000.00), less applicable withholdings and deductions.
The payments set forth in this paragraph 3 shall be delivered to Employee within five (5) business days after the expiration of the revocation period set forth in paragraph 21 of this Agreement below.
4. Employee acknowledges that he has been advised that his participation as an active employee in the Companys health insurance plans will end on October 31, 2018. Employee further acknowledges that he has been advised that he may be able to continue his health benefits pursuant to COBRA following October 31, 2018 and that Employee will receive additional information regarding COBRA under separate cover. If Employee signs and does not revoke this Agreement on or within sixty (60) days after the Release Date and if Employee elects to receive benefits pursuant to COBRA, the Company agrees to reimburse Employees COBRA premium for up to eighteen (18) months beginning on November 1, 2018 (the COBRA Payment Period). Employee agrees that in the event he accepts full-time employment at any time during
1
the COBRA Payment Period and such employment offers Employee health insurance benefits, Employee will notify the Company in writing. Notwithstanding anything set forth in this paragraph 4 to the contrary, the Companys obligation to pay Employees COBRA premium under this Agreement shall cease upon the earlier of (a) the Companys receipt of the written notice described in the immediately preceding sentence or (b) the end of the COBRA Payment Period. To the extent that Employee elects to continue to receive COBRA benefits in accordance with applicable laws after the COBRA Payment Period, Employee shall be responsible for the entire COBRA premium to the extent permitted by applicable laws.
5. The exercise period of each option to purchase shares of Company common stock granted to Employee pursuant to the Companys 2013 Equity Incentive Plan (the Equity Plan) and applicable award agreements (an Option) that is vested as of the Release Date shall be extended to the earlier of (a) the expiration of the original term of such Option, and (b) 2 years following the Release Date. All Options that are unvested on the Release Date shall be cancelled for no consideration on the Release Date and Employee shall have no further rights with respect thereto. All other terms of the Options shall continue to be governed by the Equity Plan and applicable award agreements.
6. Employee agrees that the value of the consideration provided to him pursuant to paragraphs 2, 3, 4 and 5 of this Agreement exceed any payment or remuneration to which Employee was already entitled. Employee agrees that he is not entitled to and will not seek any further consideration, including but not limited to, any wages, vacation pay, sick pay, disability pay, bonus compensation, profit sharing contributions, restricted stock, stock options, payment or benefit from Releasees (as defined in paragraph 7 of this Agreement) other than that to which he is entitled (a) pursuant to paragraphs 2, 3, 4 and 5 of this Agreement and (b) under any retirement and/or employee benefits plans (subject to the terms and conditions of such plans).
7. In consideration of the payments provided herein, Employee agrees to and hereby does release and discharge the Company, its agents, parents, subsidiaries, affiliates and its successors or assigns, directors, officers, consultants, attorneys, representatives and employees (collectively Releasees) from any and all claims, causes of action, arbitrations and demands, whether known or unknown, which he has or ever had, which are based on acts or omissions occurring up to and including the date this Agreement is fully executed. In this release, Employee further releases Releasees from any and all compensation owed to him, including vacation pay, attorneys fees, bonuses, and any damages and costs Employee could recover under any statute or common law theory. Included within this release, without limiting its scope, are claims arising out of the Employees employment or the termination of his employment based on Title VII of the Civil Rights Acts of 1964 as amended, the Civil Rights Act of 1870, the Americans with Disabilities Act of 1990 as amended, the Age Discrimination in Employment Act, as amended, the Older Workers Benefit Protection Act, the Fair Labor Standards Act of 1938 as amended by the Equal Pay Act of 1963, the Family and Medical Leave Act, the Employee Retirement Income Security Act of 1974, the Civil Rights Act of 1991, the New Jersey Conscientious Employee Protection Act, the New Jersey Law Against Discrimination, the New Jersey Wage and Hour Law, the New Jersey Family Leave Act, the U.S. Patriot Act, the Sarbanes-Oxley Act of 2002, the DoddFrank Wall Street Reform and Consumer Protection Act and any other federal, state or local civil rights, disability, discrimination, retaliation or labor
2
law, or any theory of contract, criminal, arbitral or tort law. Notwithstanding the foregoing, or anything in this Agreement to the contrary, Employee does not waive, release or discharge any of his rights with respect to (a) the enforcement of this Agreement (b) any rights which cannot be waived as a matter of law (c) Employees equity ownership in the Company (d) Employees options to purchase shares of Company common stock granted pursuant to the Equity Plan and applicable award agreements that are vested as of the Release Date, subject to the terms of the Plan and applicable award agreements (as amended pursuant to paragraph 5 above) (e) retirement benefits accrued and vested as of the Release Date (f) participation in the Companys employee benefits plans to the extent provided in such plans and all accrued and unpaid welfare benefits incurred prior to the termination of Employees participation in such plans (g) Employees indemnification rights pursuant to Section 11 of the Employment Agreement, the Companys by-laws and the Companys Certificate of Incorporation and (h) directors and liability insurance coverage pursuant to Section 11 of the Employment Agreement and his rights as insured under any such directors and officers liability insurance policy.
8. This Agreement is not an admission by the Company of any liability. The Company specifically denies and disclaims any discrimination, retaliation or injury to any person.
9. The parties agree that this Agreement may not be introduced in any proceeding, except to establish the settlement and release, the breach of this Agreement, or as may be required by law or judicial directive.
10. Employee agrees not to directly or indirectly take, support, encourage or participate in any activity or attempted activity which in any way would disparage the Releasees. Employee agrees not to write or speak about the Releasees in negative terms. The Company shall instruct each member of the Companys current Board of Directors not to (a) directly or indirectly take, support, encourage or participate in any activity or attempted activity which in any way would disparage Employee; and (b) not to write or speak about Employee in negative terms. Notwithstanding the foregoing, nothing in this paragraph 10 shall preclude Employee, the Company or the other Releasees from providing (a) truthful testimony in any judicial or administrative proceeding, (b) factually accurate statements in connection with a subpoena, regulatory inquiry or other legal process, or in legal or public filings, or (c) truthful statements made to rebut any statement regarding him.
11. The parties acknowledge that the terms of this Agreement and all discussions relating to it are confidential and agree that no party will divulge the terms of this Agreement to any third party, except that Employee may divulge such terms to (a) his immediate family, financial advisor, attorney, (b) as required by applicable laws, rules, regulations or court order or (c) as necessary to enforce his rights under this Agreement, and the Company may do so to financial advisors, attorneys, such individuals necessary for carrying out the terms and conditions of the Agreement, or as required by applicable laws, rules, regulations or court order.
12. Employee acknowledges and agrees that he shall continue to be bound by his post-employment obligations set forth in Sections 14 and 15 of the Employment Agreement. Employee represents and warrants that, except as set forth in the following sentence, as of his Release Date Employee has returned to the Company all property of the Company in Employees
3
possession, including, but not limited to, all office equipment, computer equipment and peripherals (such as laptops, printers and memory sticks), cell phones, credit cards, keys, documents, manuals, procedures, notebooks and any other Company property or Confidential Information as such term is defined in Section 14 of the Employment Agreement. The Company acknowledges and agrees that Employee is permitted to retain the Surface tablet/electronic device provided to him by the Company. In addition, Employee represents and warrants that he has (a) delivered to the Company any and all information in his possession, custody or control related to Arielle Romans employment at the Company and (b) deleted all of the Companys Confidential Information from Employees personal computers, other memory devices including the Surface and/or records.
13. Except as specifically set forth herein, this Agreement contains the complete understanding of the parties. No other promises or agreements including, but not limited to, the Employment Agreement shall be binding or shall modify this Agreement unless reduced to writing and signed by the parties hereto or counsel for the parties.
14. Employee agrees to reasonably cooperate with the Company with respect to any past, present or future legal matters that relate to or arise out of Employees employment with the Company or in the event that any claim or action is brought against the Company concerning which Employee may have knowledge or information. Employees cooperation may take the form of, among other things, Employee making himself reasonably available for interviews by the Companys counsel, providing copies of any relevant documents Employee may have, and preparing to testify and testifying at depositions, informal and formal hearings, and trials. Such cooperation should not adversely interfere with any future positions Employee may obtain or with any personal commitments. Nothing in the Agreement shall be construed to prohibit Employee from cooperating with and participating in any investigation by or action taken by federal, state, or local administrative agencies, regulatory agencies, or law enforcement agencies. Furthermore, Employees cooperation with and participation in any investigation by, or action taken by, federal, state or local administrative agencies, regulatory agencies, or law enforcement agencies will not violate any provision of this Agreement.
15. This Agreement shall be governed by New Jersey law without regard to conflicts of laws principles, and any action to enforce this Agreement must be brought and heard in a court within the State of New Jersey. The parties to this Agreement consent to personal jurisdiction in New Jersey in any action commenced to enforce its terms.
16. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.
17. Employee shall not institute nor be represented as a party in any lawsuit, claim, complaint or other proceeding against or involving Releasees based on Employees employment with the Company or upon any act or omission occurring up to and including the date this Agreement is fully executed, whether as an individual or class action, under any federal, state or local laws, rules, regulations or any other basis. Further, Employee shall not seek or accept any award or settlement from any such source or proceeding (not including unemployment insurance proceedings). In the event that Employee institutes, is a knowing
4
participant, or is a willing member of a class that institutes any such action, Employees claims shall be dismissed or class membership terminated with prejudice immediately upon presentation of this Agreement. This Agreement does not affect Employees right to file a charge with the Equal Employment Opportunity Commission (EEOC), or any similar state or local agency, or to participate in any investigation conducted by the EEOC, or any similar state or local agency, but Employee acknowledges that he is not entitled to any monies other than those payments described in this Agreement.
18. Nothing in this Agreement prohibits Employee from reporting possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. Employee does not need the prior authorization of the Company to make any such reports or disclosures and Employee is not required to notify the Company that Employee has made such reports or disclosures. Further, this Agreement does not limit Employees right to receive an award for information provided to any governmental agency or entity.
19. In accordance with the terms of the Employment Agreement, the payments provided hereunder are intended to comply with, or be exempt from, the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (Section 409A). In no event will the Company be liable for any additional tax, interest or penalties that may be imposed on Employee under Section 409A or any damages for failing to comply with Section 409A.
20. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together shall be deemed to constitute one instrument. A signature produced by facsimile, PDF or other electronic transmission shall be deemed to be an original signature.
21. Employee warrants that he is fully competent to enter into this Agreement and acknowledges that he has been afforded the opportunity to review this Agreement with an attorney for at least twenty-one (21) calendar days, that he has consulted with an attorney prior to executing this Agreement, that he has read and understands this Agreement, and that he has signed this Agreement freely and voluntarily. Further, Employee acknowledges that he has the opportunity to revoke this Agreement within seven (7) days of signing it. If Employee timely revokes his execution of this Agreement, then Employee acknowledges that this Agreement shall be of no force or effect and Employee must return any amount received hereunder. This Agreement must be executed by Employee and no longer subject to revocation no later than November 30, 2018. Employees execution of this Agreement after November 30, 2018 shall render this Agreement null and void and Employee will automatically forfeit the right to receive all payments provided pursuant to paragraphs 3, 4 and 5 of this Agreement.
PLEASE READ CAREFULLY. THIS AGREEMENT INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS. To signify their assent to the terms of this Agreement, the parties have executed this Agreement on the dates set forth under their signatures which appear below.
5
JAMES SAPIRSTEIN | CONTRAVIR PHARMACEUTICALS, INC. | |||
/s/ James Sapirstein |
|
| ||
| By: | /s/ Robert Foster | ||
|
|
| ||
| Its: | Acting CEO | ||
Date: | 10/18/2018 |
|
|
|
|
|
| Date: | 10/18/2018 |
6